IMMUTEP ADR |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.96 USD | +1.37% |
|
-1.66% | +23.33% |
| 05-17 | Capital One Initiates Immutep at Overweight Rating With $10 Price Target | MT |
| 05-15 | Immutep Says Safety Lead-in Phase of Breast Cancer Study Yields 'Encouraging' Data | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 3.010 | 3.010 | 3.330 |
| Spread/Res. | -1.66% | -1.66% | -11.11% |
| Spread/Supp. | +13.85% | +27.04% | +31.56% |
| Support | 2.600 | 2.330 | 2.250 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- IMM Stock
- IMMP Stock
- Charts Immutep ADR
